Additionally, ENHO was positively co-expressed with MHC class II presentation genes (including HLA-DMA, HLA-DOA, HLA-DPA1, HLA-DPB1, and HLA-DRB1), supporting its role in promoting anti-tumor immunity. This evidence concerns the gene HLA-DRB1 and neoplasm.